Drug Shortage Report for KETAMINE INJECTION, BP

Last updated on 2024-08-23 History
Report ID 234822
Drug Identification Number 02535645
Brand name KETAMINE INJECTION, BP
Common or Proper name KETAMINE INJECTION BP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) KETAMINE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 5 X 10 mL Vials
ATC code N01AX
ATC description ANESTHETICS, GENERAL
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2024-08-16
Estimated end date 2024-09-06
Actual end date 2024-08-22
Shortage status Resolved
Updated date 2024-08-23
Company comments Inventory remains at McKesson. Alternatively, Ketamine Injection 2 mL is available.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2024-08-23 English Compare
v5 2024-08-22 French Compare
v4 2024-08-22 English Compare
v3 2024-08-17 English Compare
v2 2024-08-08 French Compare
v1 2024-08-08 English Compare

Showing 1 to 6 of 6